pioglitazone has been researched along with Acidosis, Diabetic in 2 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdul-Ghani, M | 1 |
| Migahid, O | 1 |
| Megahed, A | 1 |
| Singh, R | 1 |
| Fawaz, M | 1 |
| DeFronzo, RA | 1 |
| Jayyousi, A | 1 |
| Rashid, O | 1 |
| Farooq, S | 1 |
| Kiran, Z | 1 |
| Islam, N | 1 |
1 trial available for pioglitazone and Acidosis, Diabetic
| Article | Year |
|---|---|
Pioglitazone prevents the increase in plasma ketone concentration associated with dapagliflozin in insulin-treated T2DM patients: Results from the Qatar Study.
Topics: Benzhydryl Compounds; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Ketoacidosis; Drug Therapy, | 2019 |
1 other study available for pioglitazone and Acidosis, Diabetic
| Article | Year |
|---|---|
Euglycaemic diabetic ketoacidosis in a patient with type 2 diabetes started on empagliflozin.
Topics: Adult; Benzhydryl Compounds; Diabetes Mellitus, Type 2; Diabetic Ketoacidosis; Drug Therapy, Combina | 2016 |